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First described as a survival factor for chick ciliary ganglion neurons, ciliaty neurotrophic factor (CNTF) has recently been shown to promote survival of chick embryo motor neurons. We now report neurotrophic effects of CNTF toward three populations of rat hippocampal neurons, the first demonstration of effects of CNTF upon rodent CNS neurons in culture. CNTF elicited an increase in the neurofilament content of hippocampal cultures prepared from embryonic day 18 (E18) rat brain. This was accompanied by increases of 2-, 28-, and J-fold in the number of GABAergic, cholinergic, and calbindin-immunopositive cells, respectively. CNTF totally prevented the 87% loss of GABAergic neurons that occurred in control cultures over 8 d. CNTF also increased high-affinity GABA uptake and glutamic acid decarboxylase activity. Effects of CNTF were in all cases dose dependent, with maximal stimulation at approximately 100 pg/ml. When addition was delayed for 3 d, CNTF failed to elicit increases either in the number of cholinergic neurons or in GABA uptake.
Until recently, NGF was the only fully characterized neurotrophic factor (Levi-Montalcini and Angeletti, 1968; Thoenen and Barde, 1980; Thoenen et al., 1987) , although a number of other putative neurotrophic factors had been described and purified (Barde, 1988 (Barde, , 1989 . Like NGF, these activities have been found to be important in supporting survival and differentiation of distinct neuronal populations in the developing nervous system (Lindsay, 1988; Purves, 1988; Barde, 1989) . Ciliary neurotrophic factor (CNTF) is among the small number of neurotrophic factors that have now been fully characterized through purification, protein sequencing, and molecular cloning. CNTF, initially purified from extracts of chick eye (Barbin et al., 1984) and subsequently from adult rat sciatic nerve (Manthorpe et al., 1986a; Lin et al., 1990) , was first described as a neurotrophic activity that promoted the survival of parasympathetic neurons of the developing chick ciliary ganglion (Adler et al., 1979; Manthorpe and Varon, 1985) . Both the molecular characteristics and neuronal specificities of CNTF distinguish it from any of the neurotrophin family of neurotrophic factors-NGF, brainderived neurotrophic factor (BDNF; Barde et al., 1982; Leibrock et al., 1989) , and neurotrophin-3 (NT-3; Hohn et al., 1990; Maisonpierre et al., 1990a) . The initial biological activities described for CNTF were limited to the PNS, where there is evidence for trophic actions of CNTF on parasympathetic, sympathetic, and some sensory neurons . To date, studies of effects of CNTF within the CNS have been limited. However, there have been several recent reports indicating effects of CNTF on the survival of developing motor neurons (Arakawa et al., 1990; Wong et al., 1990) , including an in vivo study that showed that locally applied CNTF prevented lesion-induced degeneration of motor neurons in the facial nerve nucleus following transection of the facial nerve in newborn rats (Sendtner et al., 1990 ). Another in vivo study has also suggested that CNTF may support the survival of preganglionic sympathetic spinal cord neurons (Blottner et al., 1989) . As with most neurotrophic factors, except for NGF, progress in elucidating the neuronal specificities and other biological actions of CNTF has been greatly impeded by the limited availability of the protein, this being a consequence of the low abundance of neurotrophic factors. The recent cloning of rat, rabbit, and human CNTF (Lin et al., 1989; Stiickli et al., 1989; Masiakowski et al., 199 1) has led to high-level expression and purification ofrecombinant CNTF, which will now facilitate studies of possible neurotrophic activities of CNTF toward CNS neurons.
Recent studies on the distribution ofCNTF by Northern analysis have shown CNTF mRNA to be present in several regions of the brain (N. Y. Ip, P. Masiakowski, and G. D. Yancopoulos, unpublished observations) . This raises the possibility that, in addition to its recently described effects on motor neurons, CNTF may act as a neurotrophic factor for distinct populations of CNS neurons. As part of an attempt to define the neuronal specificity(ies) of CNTF toward CNS neurons, we examined effects of CNTF on the survival and differentiation of embryonic rat hippocampal neurons in culture.
Materials and Methods
Hippocampal cell cultures. Hippocampi were dissected from embryonic day 18-l 9 (El 8-l 9) embryos of Sprague-Dawley rats and collected in FlO medium (GIBCO). The tissues were minced, rinsed twice with FlO medium, and trypsinized with 0.25% trypsin (GIBCO) for 20 min at 37°C. Trypsin was inactivated by the addition of a serum-containing medium composed of minimal essential medium (MEM) supplemented with fetal calf serum (FCS: 10%). tiutamine (2 mM). nenicillin (25 U/ ml), and streptomycin (25 '&mij.bissociateh cells'bbtained by'gentle trituration were collected and centrifuged at low speed (500 rpm) for 30 sec. The centrifugation was repeated twice, and the cell pellets were resuspended in serum-containing medium. The cells were then plated onto 6 mm microtiter wells that were coated with polyomithine (10 pg/ ml) and laminin (10 &ml). Five to six hours following the plating of cells, medium was changed to a serum-free medium containing N3 supplements (Romijn et al., 1982) and penicillin-streptomycin (25 U/ml and 25 &ml. resuectivelv). at which time CNTF was added. Medium was changed every 3-4 &with readdition of the factor. Except where noted, the plating density used for the experiments described in the present study was 7 1,000 cells/cm'.
To obtain neuron-enriched cultures, cytosine arabinoside (1 PM) or fluorodeoxyuridine (FUdr) (15 &ml) and uridine (35 &ml) were added for a period of 24 hr. Under such conditions, the hippocampal cultures contain approximately 9% glial cells following 8 d in culture, as assessed by ghal fibrillary acidic protein (GFAP) immunohistochemistry.
Assay for glutamic acid decarboxylase (GAD) enzyme activity. GAD enzyme activity was determined according to the method of Kimura and Kuriyama (1975) by measuring the release of 14C0, from L-[ 1 -'"Clglutamic acid. Cells on 35-mm dishes were lysed with 30 ~1 of a solution containing 50 mM KH,PO, (pH 7.2) and 0.25% Triton X-100, scraped, and collected. Five microliters of the cell lvsate was assayed for GAD enzyme activity. In a typical assay, the reaction mixture contained 0.57 mM L-[ l-14C]-gIutamic acid [New England Nuclear (NEN), NEC-715; 52.6 mCi/mmol], glutamic acid (3 mM), pyridoxal phosphate (0.2 mM), and 2-aminoethylisothiouronium bromide (AET, 1 mM), in a KH,PO, buffer (50 mM, pH 7.2). Under these reaction conditions, the enzyme reaction was found to be linear for up to 2.5 hr. An incubation period of 2 hr at 37°C was routinely used and the reaction was terminated by injecting 25 ~1 of 8N H,SO, into the reaction mixture. The incubation was then continued for another 60 min. 14C-CO, released was trapped in methyl benzethonium hydroxide and was counted.
Measurement of neurojilament protein. Neurofilament protein was quantitated according to the method by Doherty et al. (1984) . Following fixation with 4% (v/v) paraformaldehyde for at least 4 hr at 4°C the cultures were permeabilized with 0.1% (v/v) Triton X-100 in PBS for 15 min and blocked with 10% heat-inactivated FCS in PBS for 1 hr. The cultures were then incubated with mouse anti-neurofilament immunoglobulin (RT97, l:lOOO) for I hr at room temperature, washed twice with PBS containing 10% FCS, and incubated with the secondary antibody (horseradish peroxidase-conjugated sheep anti-mouse at 1:500 dilution) for 1 hr. Following sequential washing with PBS and water, the cultures were incubated with 0.2% (w/v) O-phenylenediamine and 0.02% (v/v) H,O, in citrate buffer (50 mM) for 30 min. The reaction was stopped by adding an equal volume of 4.5 M H,SO,. Product formation was quantitated by reading the optical density (O.D.) of an aliquot of the reaction product at 492 nm using the Flow Titretek multiscan apparatus.
Measurement of high-affinity uptake for GABA. High-affinity GABA uptake was measured using a modified procedure of Tomozawa and Appel (I 986) . Cells were washed in the GABA uptake buffer containing 140 mM NaCl, 2.5 mM KCI, I mM KH,PO,, 1 mM Na,HPO,, 6 mg/ml glucose, I mM MgCl,, 1 mM CaCl,, and0. 1% BSA. Following washing, cells were incubated with the GABA uptake buffer for 5 min at 37°C. 'H-GABA (NEN, 111.4 Ci/mmol) was then added at a final concentration of 12 nM, and incubation was carried out at 37°C for 10 min. Cells were kept on ice and washed three times with the uptake buffer. Cells were then incubated with 0.14N NaOH for 2 hr at room temperature, and 'H-GABA in the extract was counted. )H-GABA uptake was found to be linear for up to at least 30 min. Uptake of GABA into non-neuronal cells was inhibited by the addition of 2 mM @-alanine, whereas uptake specific for neurons is verified by inhibition with nipecotic acid at 1 mM. Nipecotic acid was found to inhibit total GABA uptake in hippocampal cultures by 88%. Specific neuronal GABA uptake was determined as GABA uptake that was blocked in the presence of 1 mM nipecotic acid. It is noteworthy that CNTF treatment only affected the GABA uptake that was blocked by nipecotic acid, and not the level of nipecotic acid-independent GABA uptake.
Immunohistochemical staining for GAD or GABA. Cells were fixed with 4% paraformaldehyde for 30 min at room temperature and washed with PBS. For GAD staining, cells were permeabilized by sequential rinsing with 50%. 70%. and 50% ethanol. The cultures were blocked with PBS containing 5% normal rabbit serum for 1 hr and incubated with sheen anti-GAD antibodv 1440 (1:6000) overnight at 4°C. Following three rinses with PBS, ceils were then incubated \;ith biotinylated rabbit anti-sheep antibody at a 1:400 dilution for at least 90 min at room temperature. For GABA staining, cells were permeabilized with Triton X-100 (0.25%) in Tris-HCI (0.1 M, pH 7.3) and blocked with 10% normal goat serum (NGS) for 90 min, prior to incubation with rabbit anti-GABA antibody (1:5000) overnight at 4°C. Following three rinses with PBS, cells were then incubated with the biotinylated goat anti-rabbit antibody at a I:200 dilution for at least 90 min at room temperature. GAD-or GABA-immunoreactive cells were visualized using the Vectastain ABC kit (Vector Labs).
Immunohistochemical staining for neuron-speccific enolase, calbindin, or ChAT. Cells were rinsed twice with PBS and fixed with 4% naraformaldehyde for 30 min at room temperature. For neuron-specific-enolase (NSE) staining, cells were blocked with 10% normal goat-serum in PBS containina 0.1 O/o Triton X-100. The cells were then incubated with the primary antibody (rabbit anti-NSE, 1:5000) overnight at 4°C prior to incubation with the secondary antibody (goat anti-rabbit, I:200 dilution) for at least 90 min at room temperature. For calbindin staining, cells were permeabilized, washed with 1% normal horse serum (NHS), and blocked with 5% NHS in PBS for 1 hr at room temperature. Cells were then incubated with a mouse antibody raised against the 28-kDa species of calbindin (1:lOOO) in 1% NHS overnight at 4°C prior to incubation with the secondary antibody (biotinylated horse anti-mouse, 1:400) for 90 min at room temperature. For ChAT staining, cells were permeabilized with Triton X-100 (0.25%) in Tris-HCI (0. I M, pH 7.3) and blocked with 10% normal rabbit serum for 60 min prior to incubation with a rat anti-ChAT monoclonal antibody (1:200) overnight at 4°C. Incubation with the secondary antibody (rabbit anti-rat, I: 1500) was for 60 min at room temperature. Immunoreactive cells for NSE or calbindin were visualized by using the Vectastain ABC kit.
Histochemical staining for acetylcholinesterase. Histochemical staining for acetylcholinesterase was performed according to the procedures of Geneser-Jensen and Blackstadt (197 I). Cells were washed three times with PBS and fixed with 4% paraformaldehyde at room temperature for 30 min. The fixed cells were then incubated with a reaction mixture containing 50 mM acetate buffer (pH 5.0) 4 mM acetylthiocholine iodide, 2 mM copper sulfate, 10 mM glycine, and 10 Fdrnl gelatin. Nonspecific cholinesterases were inhibited by including 0.2 mM ethopropazine in the incubation medium. Specificity of the cholinesterase staining was verified by the addition of neostigmine at 5 PM. In the presence of neostigmine, no AChE-positive cells were observed. At the end of a 7 d incubation, gelatin was dissolved by brief incubation at 37°C. The cells were washed with water, treated for 1 min with 1.25% Na,S, and washed again with water. They were then treated for 1 min with 1% AgNO, and washed with water and PBS.
Purification of CNTF. The purification of recombinant rat CNTF used for the present study was carried out as described previously (Masiakowski et al., 1991) .
Results

CNTF sustains survival of hippocampal neurons
Hippocampal neurons from E 18 rat embryos, when plated on polyomithine-laminin coated tissue culture dishes, exhibited rapid neurite outgrowth by 7 hr in culture (Fig. 1A) . Continued neurite extension was visually notable for the first few days in culture. During this period, there were few non-neuronal cells present (Fig. l&D) .
Without treatment to reduce non-neuronal cell proliferation, the neuronal population represented more than 60% of the total cell number by the end of 8 d in culture (Fig.  1E ). There were no apparent differences in neuronal morphologies observed between control and CNTF-treated cultures during the first 4 d in vitro. Between 4 and 8 d, however, there was a large decrease in the number of neurons in control cultures.
In initial experiments, immunoreactivity for NSE was used as a marker to examine the effect of CNTF on neuronal number following 8 d of treatment (Fig. lF,G) . By this criterion, the number ofneurons in CNTF-treated cultures was approximately twofold higher than in untreated controls. This effect of CNTF on the number of NSE-positive cells was essentially the same at the standard and lower plating densities used (Fig. IA-E and F, G, respectively).
Neurojilament protein content is increased by CNTF
To examine any broad effects of CNTF on neut-ite outgrowth in hippocampal cultures, levels of neurofilament protein were Figure I . Hippocampal cell cultures. Phase-contrast photomicrographs of hippocampal cultures following 7 hr and 1, 2, 4, and 8 d in culture are shown in A-E, respectively. F and G show neurons identified with NSE following 8 d in culture in the absence or presence of 10 r&ml CNTF, respectively. Cells were plated at a density of 7 1 ,OOO/cmZ for A-E, and 25,00O/cm* for F and G. Scale ham, 50 pm. measured using an ELISA, as previously described (Doherty et rig/ml) produced a 50% increase in neurofilament protein levels al., 1984, 1987) . The RT97 monoclonal antibody that was used after 6 d, which was further increased to 480% of control levels recognized predominantly the 200 kDa form of the neurofilaby day 8 in culture. The large difference between neurofilament ment protein triplet (Robinson and Anderton, 1988) . CNTF (10 levels in control and CNTF-treated cultures after 8 d partly Hippocampal cultures were maintained in the presence or absence of CNTF (10 &ml) for 8 d, and the numbers ofChAT-or AChE-positive cells were determined. Results are the mean ? SEM (n = 5-10).
reflected an increase in neurofilament protein in treated cultures and partly reflected the degeneration and loss of neurons in untreated cultures. When compared to untreated controls following 8 d in culture, neurofilament protein levels increased in a dose-dependent manner with CNTF treatment (Fig. 2) . The response to CNTF was maximal at 0.1 @ml, representing a sixfold increase compared to untreated controls, while the EC,, was calculated to be 0.02 r&ml (0.9 PM). Higher concentrations of up to 10 &ml did not further increase the response.
CNTF increases the number of GABAergic, cholinergic, and calbindin-immunopositive cells The large increase in neurofilament protein in response to CNTF treatment suggested that a relatively large percentage of the neurons were responding to the factor. The responding neuronal population(s) was further delineated on the basis of immunoand histochemical staining (Fig. 3) . Based on GABA or GAD immunoreactivity, approximately 20% of the neurons in control cultures were GABAergic, following 8 d in culture. In the presence of CNTF, there was an approximately twofold increase in the number of GABAergic neurons (Figs. 3A,B; 4A ). The effect of CNTF on GABAergic cells was further confirmed by GAD immunohistochemical staining, where a similar increase of twofold was observed with CNTF treatment (data not shown).
Putative effects of CNTF on two other cell populations of hippocampal neurons, cholinergic and calbindin-immunopositive cells, were examined (Fig. 3C,E) . Based on previous studies that have reported the presence of a small population of intrinsic cholinergic neurons in the hippocampus (Storm-Mathisen, 1970; Fonnum et al., 1979; Frotscher et al., 1986) , we examined the number of AChE-positive cells in our cultures. In untreated cultures following 8 d in vitro, AChE-positive cells made up a very small percentage (0.2%) of the total number of neurons. In agreement with previous observations (Frotscher et al., 1986) , the AChE-positive cells were relatively small and were weakly stained (Fig. 3C ). Treatment ofcultures with CNTF produced a large increase in the number of AChE-positive cells compared to untreated controls, approximately 28-fold, when examined after 8 d (Figs. 30, 4B) . AChE staining by itself is not sufficient to define a cholinergic phenotype. However, as we observed a similar fold increase in the number of ChAT-immunopositive cells following CNTF treatment (Table l) , we feel that the majority of the AChE-positive cells do represent cholinergic neurons. Interestingly, in contrast to what has been observed in cultures of other CNS cholinergic neurons (Hartikka and Hefti, 1988; Alderson et al., 1990) , NGF produced no significant increase in the number of AChE-positive cells when tested at concentrations of lo-50 &ml (data not shown). In untreated cultures, a small number of calbindin-immunopositive cells were found (Fig. 3E) labeling experiments showed that calbindin-and GABA-immunopositive cells represent distinct cell populations (data not shown). In the presence of CNTF, the number of calbindinimmunopositive cells was increased by threefold (Figs. 3F, 4B ). Taken together, these data suggest that CNTF can enhance the survival and/or expression of phenotypic markers of several subpopulations of hippocampal neurons in culture.
CNTF rescues virtually all GABAergic neurons A detailed time course of the loss of GABA-immunopositive cells in control or CNTF-treated cultures was examined. As shown in Figure 5A , there was a gradual decline in the number of GABA-immunopositive cells in the control cultures between 1 and 8 d. By day 8, the number of GABA-immunopositive cells in control cultures was only 33% of that found in similar cultures on day 1. In contrast, in CNTF-treated cultures, the number of GABA-immunopositive neurons on days 4, 6, and 8 remained essentially constant, similar to that determined on day 1. Thus, the data suggest that CNTF addition sustained survival of virtually all GABAergic neurons during the culture period. Similar studies were carried out using the general neuronal marker NSE (Fig. 5B) . In control cultures, there was a gradual decline in the number of NSE-immunopositive cells after day 1, with the number of neurons on day 8 falling to approximately 10% of that found on day 1. In the presence of CNTF (10 @ml), the total number of NSE-immunopositive cells on day 8 was about 2.8-fold higher than that seen in control cultures.
GABA uptake and GAD activity are increased by CNTF In addition to studying effects on neuronal survival, the effect of CNTF on GABAergic phenotype expression was investigated by measuring changes in the level of high-affinity uptake of GABA and the levels of GAD activity in control and CNTFtreated cultures. CNTF treatment produced a 50% increase in GABA uptake by 5 d in culture, while a maximal increase of approximately fourfold, compared to controls, was observed after 8 d of CNTF treatment (Fig. 6) . Longer culture periods of up to 11 d did not produce a greater effect of CNTF (see 8B). Treatment of cultures with 50 &ml NGF did not result in any increase in high-affinity GABA uptake (data not shown). The response of the high-affinity GABA uptake to increasing concentrations of CNTF is shown in Figure 7A . A maximal increase of threefold in specific neuronal GABA uptake was observed with 0.1 rig/ml of CNTF. The response was saturable and was maximally stimulated even at a loo-fold higher concentration of CNTF. GAD activity was also observed to be increased following CNTF treatment and was maximally increased by 3.8-fold following treatment with 0.1 rig/ml CNTF (Fig. 7B) .
Is the effect of CNTF mediated by non-neuronal cells?
Cultures of astroglial cells have been shown both to express and to release into culture medium a number of neurotrophic activities, including NGF, as reviewed in Manthorpe et al. (1986b) . Given that our cultures contained a significant percentage of astroglial cells immunopositive for GFAP, we were interested to determine whether or not our observed effect of CNTF on hippocampal neurons might be indirectly mediated through action of CNTF on glial cells, as opposed to a direct action of Hippocampal cultures were maintained in the presence or absence of CNTF (1 i&ml) for 8 d. AraC (0.3 or 1 PM) or F'Udr (15 &ml) and uridine (35 &ml) were added to the hippocampal cultures for 24 hr to reduce the number of glia. High-affinity specific neuronal GABA uptake was measured on day 8 in culture.
The results represent the level of GABA uptake of treated cultures expressed as a percentage of untreated control cultures f SEM (n = 6). of cultures treated with these antimitotic agents showed depletion ofnon-neuronal cells. Based on immunoreactivity for GFAP, treatment of cultures with 0.3 or 1 PM AraC (or 15 &ml FUdr) resulted in a 57% and 77% reduction of the glial population, respectively. Under these conditions, the maximum response to CNTF in glial-depleted cultures was essentially the same as in our standard cultures. As shown in Table 2 , in cultures treated with 0.3 I.~M AraC, 1 rig/ml CNTF produced a maximum response of 2.6-fold increase in GABA uptake when compared to untreated controls. A CNTF-induced response of 3.2-fold was similarly observed in the presence of 1 PM AraC. Thus, the foldstimulation in GABA uptake was similar in standard cultures (-AraC) and in neuron-enriched cultures (+AraC). Similar results were obtained with FUdr. Although complete elimination of non-neuronal cells was not achieved, the above data tend to argue against a role of astrocytes mediating the action of CNTF and suggest that the effect is mediated via a direct action on neurons. In this context, it is noteworthy that recent studies have provided direct evidence for a neuronal binding site for CNTF on peripheral neurons (Squint0 et al., 1990) .
Delaying the addition of CNTF results in a loss of responsive cells To distinguish between the possibilities of a survival-promoting effect and a phenotypic differentiation effect of CNTF on GABAergic neurons, CNTF was added at various times after plating, and the effect on the level of neuronal GABA uptake was measured. In the first set of experiments (Fig. 8A) , CNTF was added after a delay of 5 hr or 1, 2, 3, or 4 d, and the cultures were maintained for a total of 8 d. Cultures that received CNTF (10 rig/ml) for the entire culture period showed a 420% increase in GABA uptake. A delay of 2 d (-2/+6) in the addition of CNTF resulted in only a 240% increase in GABA uptake, while a delay of 3 d (-3/+5) resulted in a total loss of the response. cells to respond maximally to CNTF. In this experiment, cultures that had not received CNTF for 3 d were grown in the presence of CNTF for a further 8 d, thus extending the culture period to 11 d. However, no increase in GABA uptake was observed even after this additional time in culture (Fig. 8.4 , inset). The question as to whether or not all responsive neurons require CNTF for survival was addressed by similar delayed addition experiments where neurofilament protein content was measured. Results were essentially the same as seen for GABA uptake; that is, no increase in the neurofilament protein content compared to untreated controls was seen when the addition of CNTF was delayed for 3 or more days. Similar experiments were performed to examine the effects of delaying the addition of CNTF on the number of AChE-positive cells. Whereas treatment ofcultures with CNTF for the entire period of 8 d produced a 28-fold increase in the number of AChE-positive cells, delaying the addition of CNTF for 3 d failed to elicit any increase in the number of cholinergic neurons (Fig. 8B) . Therefore, on the basis of neurofilament protein, GABA uptake, and AChE histochemistry, a delay in the addition of CNTF appeared to result in a loss of responsive neuronal cell populations.
Discussion CNTF distinguishes itself from the recently identified neurotrophin family of neurotrophic factors (Leibrock et al., 1989; Maisonpierre et al., 1990a) in both molecular characteristics and biological specificities. Although the mechanism of release of CNTF from its site of synthesis is currently unknown, it is now well documented that CNTF has clearly defined actions toward several distinct neuronal populations in culture (Emsberger et al., 1989; Saadat et al., 1989) , including parasympathetic neurons of the chick ciliary ganglion (Barbin et al., 1984; Manthorpe and Varon, 1985) and motor neurons (Arakawa et al., 1990) . In this article, we have provided evidence of a novel action of CNTF toward embryonic rat hippocampal neurons in culture. Treatment of hippocampal neurons with CNTF was first observed to result in a large increase in neurofilament protein levels when compared to untreated controls. Using neuronal subtype-specific markers, we have subsequently defined three subpopulations of hippocampal neurons whose survival were enhanced in the presence of CNTF. In the absence of neuronal markers whose expression is independent of trophic factor, it is of course difficult in control cultures to distinguish between death of a minor population of neurons or loss of the phenotypic marker that defines that population. This issue has been difficult to address with almost all in vitro studies with NGF. Whereas it is possible that some of the effects of CNTF were due to selective induction of specific phenotypic markers rather than enhancement of survival, the results of the delayed addition experiments argued against the former. Furthermore, the effects of CNTF were not diminished in cultures depleted of non-neuronal cells, suggesting that the actions of CNTF were not mediated via glial cells. Hippocampal neurons in culture have been well characterized in terms of morphology, neurotransmitter content (Banker and Cowan, 1977, 1979; Mattson, 1988) , and electrophysiological properties, as reviewed in Mayer and Westbrook (1987) . Studies on the developmental profile of neuronal cell-type morphology have shown that neurons in culture differentiate in a manner that closely represents the in vivo situation (Banker and Cowan, 1979; Bartlett and Banker, 1984a,b) . However, few studies have examined possible trophic effects of defined growth factors upon hippocampal neurons in culture. The observation that survival of hippocampal neurons in culture was enhanced in the presence of astrocytes (Banker, 1980; Miiller and Seifert, 1982) was the first to suggest that glial cells might provide trophic support for these neurons. In light of what is now known, it is possible that the trophic activity derived from astrocytes may have been CNTF or basic FGF (bFGF) or a member of the neurotrophin family. In this context, it has been reported that bFGF promotes the survival of hippocampal neurons (Walicke, 1986) . Beyond this, there is little information on the effects of known neurotrophic factors on hippocampal neurons.
In the present study, we have observed on average a 2.4-fold increase in neuronal cell number in CNTF-treated hippocampal culture following 8 d in vitro. Interestingly, this increase in cell survival was accompanied by a greater (fivefold) increase in neurofilament protein levels. This difference suggests that CNTF may promote neurite outgrowth in addition to its effect on cell survival. The time course of the increase in neurofilament protein in hippocampal cultures is of interest in that we did not observe a significant difference in neurofilament protein content between CNTF-treated and untreated controls until day 6 in Figure 8 . Effects of delaying the addition of CNTF on the CNTFinduced increase in high-affinity specific neuronal GABA uptake. A, CNTF ( 10 rig/ml) was added following a delay of 5-6 hr (+ 8) or 1 (-I/ +7), 2 (-2/+6), 3 (-J/+5), or 4 d (-4/+4) after cells were plated. High-affinity specific neuronal GABA uptake was determined on day 8 in culture. -8 indicates control cultures without CNTF treatment. Inset, CNTF (10 @ml) was added to the cultures following a delay of 5-6 hr (+ II) or 3 d (-3/+8), and high-affinity specific neuronal GABA uptake was determined on day 11 in culture. -11 indicates control cultures without CNTF treatment. B, CNTF (10 rig/ml) was added following a delav of 5-6 hr (+8) or 1 (-l/+71. 2 t-2/+6). or 3 d c-3/+5) after the iells were plated. His&hem&l siaining for AChElpositivk cells was performed on day 8 in culture (n = 10). -8 indicates control cultures without CNTF treatment. The results represent the mean + SEM.
culture. One potential influence on the early development of hippocampal neurons in vitro is the presence of endogenous trophic activity. For example, CNTF-like activity has been detected in the culture medium of glial cells 1 d after plating but was absent at later times (Rudge et al., 1985) . Thus, it is possible that early in the culture period there was sufficient endogenous levels of trophic activity to enhance survival and initiate expression of neurofilament protein, such that the immediate actions of exogenous CNTF were not obvious.
GABAergic cells were one of the major cell types that were found to be responsive to CNTF. In agreement with previous studies (Walker and Peacock, 1982; Seifert et al., 1983; Hoch and Dingledine, 1986) , the percentage of GABAergic cells in our cultures was approximately 20%. We observed not only an campal neurons supported by CNTF was relatively small (Fig.  increased number of GABAergic cells, as determined by im-5). This is indicative of the limited specificity of CNTF for the munocytochemistry, but also increases in GABA uptake and three populations described. However, the increment in NSE-GAD enzyme activity in CNTF-treated cultures. Over the 8 d positive cells at 8 d, as a consequence of CNTF treatment, was time course of our experiments, there was virtually no loss of larger than that accounted for by the observed increase in the GABAergic cells when CNTF was present. In accordance with number of GABAergic, cholinergic, and calbindin-immunothe fact that GABA is an inhibitory transmitter, our finding that positive cells. This would argue that there is at least another CNTF increases the number of GABAergic neurons in vitro may population of hippocampal neurons that is responsive to CNTF. have important physiological implications in vivo.
We are currently establishing reliable markers to investigate the The survival-promoting activity of CNTF on hippocampal effects of CNTF on other neuronal populations such as the gluneurons does not appear to be limited to GABAergic neurons. tamatergic neurons. We have observed that the number of AChE-immunopositive
The specificity of the response of hippocampal neurons to cells was greatly increased in the presence of CNTF. The mag-CNTF was addressed by examining the actions of other neunitude of the increase (28-fold) was much higher than that obrotrophic factors, especially those of the neurotrophin family. served for GABAergic neurons. Furthermore, the intensity of The latter are of particular interest in that not only is NGF the AChE histochemical staining was also much more proexpressed at high levels in the hippocampus (Korsching et al., nounced in CNTF-treated cultures, suggesting that CNTF is 1985; Shelton and Reichardt, 1986; Large et al., 1987) but also capable of enhancing the phenotypic marker specific for such both BDNF and NT-3 mRNA levels are abundant in the hipneurons. A similar increase in the number ofcholinergic neurons pocampal formation (Maisonpierre et al., 1990b ). We were not was also observed using ChAT immunocytochemistry. Exable to detect any effect of NGF on GABAergic neurons or tremely low abundance of such cholinergic neurons precluded cholinergic neurons in hippocampal cultures. These data suggest more detailed analysis by either ChAT or AChE enzyme assay. that the effect of CNTF was not mediated via the release of In marked contrast to the well-documented effect of NGF on NGF from hippocampal cells. However, we cannot rule out the cholinergic neurons in septal cultures (Hartikka and Hefti, 1988;  possibility that the actions of CNTF might have been mediated Alderson et al., 1990) we found no such effect of NGF on the indirectly through BDNF or NT-3 or an as yet unidentified number of AChE-positive neurons in hippocampal cultures.
factor. Thus, these data, taken together, not only suggest a novel role mRNA for CNTF has recently been detected in the CNS, for CNTF on a CNS cholinergic cell population but also indicate including the hippocampal formation, by Northern blot analysis that this effect is not mediated by an indirect release of NGF (Ip, Masiakowski, and Yaneopoulos, unpublished observafrom astrocytes present in the cultures. In light of a previous tions). The cell-type specificity of CNTF synthesis in hippocamstudy in which CNTF was not found to enhance ChAT activity pus in vivo, however, has not yet been delineated. Similar to in cultures of septum or pons (Knusel and Hefti, 1988) our bFGF, sequence analysis of CNTF shows that it lacks a typical results suggest that CNTF acts on select populations of CNS signal sequence, and it is thus not yet clear how CNTF could cholinergic neurons.
be made available to neurons. There is now considerable evi-A third cell type that was affected by CNTF was cells imdence that at least two members of the neurotrophin family munopositive for calbindin, one of a class of calcium-binding (NGF and BDNF), which are expressed at high levels in the proteins (CaBP) that bind Ca2+ with high affinity (Persechini et hippocampus, may act as target-derived factors for neuronal al., 1989). Immunohistochemical studies have shown a widepopulations that project to the hippocampus (Hartikka and Hefspread distribution of the 28 kDa species of calbindin in the ti, 1988; Alderson et al., 1990) . CNTF, on the other hand, may CNS (Bairnbridge and Miller, 1982;  be different, acting in a local manner on hippocampal neurons. Feldman and Christakos, 1983) . In the hippocampus, calbindin
The hippocampal formation has been shown to be affected has been localized to the somata of cells positioned in the moin several neurodegenerative disorders, including Alzheimer's lecular and granule cell layers of the dentate region and in the disease (Hyman and Hoesen, 1989) . The underlying mecha-CA1 region (Bairnbridge and Miller, 1982) . Relatively little is nisms that lead to the selective neuronal degeneration within known concerning the regulation or the physiological function the hippocampus are not well understood. It has been hypothof calbindin in brain. However, in a recent study, decreases of esized that the excitatory amino acid neurotransmitter glutaup to 60-80% in the levels of both the message and protein for mate may be involved in the disease process (Schwartz et al., calbindin were observed in the hippocampus of patients who 1984; Maragos et al., 1987; Choi, 1988) . Thus, it will be interwere diagnosed as having Parkinson's, Huntington's, or Alzheiesting to investigate whether CNTF is able to protect hippomer's disease (McLachlan et al., 1987; Iacopino and Christakos, campal neurons against the well-documented neurotoxicity of 1990). In addition, it has recently been shown that the presence glutamate (Foster et al., 1988; Mattson et al., 1988) . Although of calbindin in specific regions of the hippocampal formation the physiological role of CNTF in the hippocampus during demay be positively correlated with the relative resistance of such velopment in vivo remains to be established, in view of the neurons to seizure-induced neuronal damage (Sloviter, 1989) . present findings, CNTF may be an endogenous neurotrophic In the present study, we have shown that the number of calfactor with a potential role in regulating neuronal survival in bindin-immunopositive cells was increased by threefold followthe hippocampus. ing CNTF treatment. Such an increase in Ca2+-binding capacity may have a significant physiological implication in that it may be important in preventing cell death in select populations of References 
